1. Home
  2. BCAB vs ITRG Comparison

BCAB vs ITRG Comparison

Compare BCAB & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • ITRG
  • Stock Information
  • Founded
  • BCAB 2007
  • ITRG 1997
  • Country
  • BCAB United States
  • ITRG Canada
  • Employees
  • BCAB N/A
  • ITRG N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • ITRG Precious Metals
  • Sector
  • BCAB Health Care
  • ITRG Basic Materials
  • Exchange
  • BCAB Nasdaq
  • ITRG Nasdaq
  • Market Cap
  • BCAB 31.5M
  • ITRG 452.9M
  • IPO Year
  • BCAB 2020
  • ITRG N/A
  • Fundamental
  • Price
  • BCAB $0.70
  • ITRG $2.79
  • Analyst Decision
  • BCAB Hold
  • ITRG Strong Buy
  • Analyst Count
  • BCAB 3
  • ITRG 2
  • Target Price
  • BCAB $1.00
  • ITRG $3.25
  • AVG Volume (30 Days)
  • BCAB 1.0M
  • ITRG 2.2M
  • Earning Date
  • BCAB 11-06-2025
  • ITRG 11-12-2025
  • Dividend Yield
  • BCAB N/A
  • ITRG N/A
  • EPS Growth
  • BCAB N/A
  • ITRG N/A
  • EPS
  • BCAB N/A
  • ITRG 0.09
  • Revenue
  • BCAB $11,000,000.00
  • ITRG $148,447,000.00
  • Revenue This Year
  • BCAB N/A
  • ITRG $871.24
  • Revenue Next Year
  • BCAB N/A
  • ITRG N/A
  • P/E Ratio
  • BCAB N/A
  • ITRG $31.60
  • Revenue Growth
  • BCAB N/A
  • ITRG N/A
  • 52 Week Low
  • BCAB $0.24
  • ITRG $0.79
  • 52 Week High
  • BCAB $2.53
  • ITRG $2.75
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 68.12
  • ITRG 83.79
  • Support Level
  • BCAB $0.44
  • ITRG $2.54
  • Resistance Level
  • BCAB $0.84
  • ITRG $2.75
  • Average True Range (ATR)
  • BCAB 0.08
  • ITRG 0.12
  • MACD
  • BCAB 0.03
  • ITRG 0.03
  • Stochastic Oscillator
  • BCAB 70.08
  • ITRG 95.68

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

Share on Social Networks: